Novartis

News

Novartis shares fall as Entresto sales weaken

Novartis is showing the effects of its patent cliff more strongly, with generic competition hitting sales and profits in the first quarter of 2026.

News

New data build case for Roche's oral BTK drug for MS

Roche remains confident in the prospects for its soon-to-be-filed oral BTK drug fenebrutinib for multiple sclerosis, despite safety concerns.

News

Novartis CEO joins board of "responsible" AI firm Anthropic

In another signal of the deepening relationship between the pharma and AI sectors, Novartis CEO Vas Narasimhan has joined the board of Anthropic.

News

Novartis snaps up food allergy firm Excellergy for $2bn

Novartis has signed its second M&A deal in the space of a week, pledging to pay up to $2 billion to acquire US food allergy drug developer Excellergy.

News

Patient sues Novartis, claiming data-tracking privacy breach

A cancer patient in the US has filed a class action lawsuit against Novartis in the US, claiming that the company shared her private health data.

News

Novartis snaps up PI3Kα breast cancer drug in $3bn deal

Novartis has agreed to buy a PI3Kα-targeting drug for breast cancer from Synnovation, a potential successor to its Piqray brand, for $2bn upfront.

Novartis shares fall as Entresto sales weaken

New data build case for Roche's oral BTK drug for MS

Novartis CEO joins board of "responsible" AI firm Anthropic

Novartis snaps up food allergy firm Excellergy for $2bn

Patient sues Novartis, claiming data-tracking privacy breach

Novartis snaps up PI3Kα breast cancer drug in $3bn deal

Reports: Makary out, Diamantas in as FDA commissioner

Discover a new era of healthcare panel engagement: Grounded ...

Novartis

Editor's Picks